Switch to:
Also traded in: Germany, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 5.48
LFWWF's Cash-to-Debt is ranked higher than
59% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.55 vs. LFWWF: 5.48 )
Ranked among companies with meaningful Cash-to-Debt only.
LFWWF' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.89  Med: 2.23 Max: 241.3
Current: 5.48
0.89
241.3
Equity-to-Asset 0.62
LFWWF's Equity-to-Asset is ranked lower than
51% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. LFWWF: 0.62 )
Ranked among companies with meaningful Equity-to-Asset only.
LFWWF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.33  Med: 0.62 Max: 0.76
Current: 0.62
0.33
0.76
Piotroski F-Score: 6
Altman Z-Score: 3.38
Beneish M-Score: -2.59
WACC vs ROIC
-2.03%
-26.83%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating Margin % -6.57
LFWWF's Operating Margin % is ranked lower than
61% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.62 vs. LFWWF: -6.57 )
Ranked among companies with meaningful Operating Margin % only.
LFWWF' s Operating Margin % Range Over the Past 10 Years
Min: -34.32  Med: -3.93 Max: 21.6
Current: -6.57
-34.32
21.6
Net Margin % -11.64
LFWWF's Net Margin % is ranked lower than
63% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 1.55 vs. LFWWF: -11.64 )
Ranked among companies with meaningful Net Margin % only.
LFWWF' s Net Margin % Range Over the Past 10 Years
Min: -38.87  Med: -1.62 Max: 23.74
Current: -11.64
-38.87
23.74
ROE % -39.89
LFWWF's ROE % is ranked lower than
74% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 1.31 vs. LFWWF: -39.89 )
Ranked among companies with meaningful ROE % only.
LFWWF' s ROE % Range Over the Past 10 Years
Min: -58.77  Med: -4.34 Max: 47.01
Current: -39.89
-58.77
47.01
ROA % -16.02
LFWWF's ROA % is ranked lower than
63% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 0.06 vs. LFWWF: -16.02 )
Ranked among companies with meaningful ROA % only.
LFWWF' s ROA % Range Over the Past 10 Years
Min: -38.43  Med: -2.33 Max: 29.72
Current: -16.02
-38.43
29.72
ROC (Joel Greenblatt) % -46.42
LFWWF's ROC (Joel Greenblatt) % is ranked lower than
63% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 4.26 vs. LFWWF: -46.42 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
LFWWF' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -263.69  Med: -19.64 Max: 154.16
Current: -46.42
-263.69
154.16
3-Year Revenue Growth Rate 6.80
LFWWF's 3-Year Revenue Growth Rate is ranked higher than
59% of the 237 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. LFWWF: 6.80 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
LFWWF' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -16  Med: 3.55 Max: 19.5
Current: 6.8
-16
19.5
3-Year EBITDA Growth Rate 3.20
LFWWF's 3-Year EBITDA Growth Rate is ranked lower than
54% of the 208 Companies
in the Global Medical Devices industry.

( Industry Median: 5.10 vs. LFWWF: 3.20 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
LFWWF' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -71.1  Med: 3.2 Max: 93.8
Current: 3.2
-71.1
93.8
GuruFocus has detected 4 Warning Signs with LifeWatch AG $LFWWF.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» LFWWF's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with LFWWF

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices  
Compare:NAS:CUTR, AMEX:CVRS, NAS:RTIX, OTCPK:XVIPF, NAS:TCMD, NAS:AXGN, NAS:OBLN, NAS:EXAC, NAS:ELOS, NYSE:IVC, NAS:ACRX, NAS:ARAY, NAS:IRIX, OTCPK:JLFNF, NAS:NVCN, NAS:FONR, NAS:CGNT, NAS:MSON, NAS:DRAD, NAS:IRMD » details
Traded in other countries:GUA1.Germany, LIFE.Switzerland, 0QLI.UK,
Headquarter Location:Switzerland
LifeWatch AG is a health care services and technology company. The company provides remote wireless diagnostic monitoring services as well as develop and manufacture advanced digital health systems.

LifeWatch AG was incorporated in was incorporated in July 2001, under the name Remmedtech AG, on August 14, 2001 changed its name to Card Guard AG and on May 26, 2009 changed its name to LifeWatch AG. The Company and its subsidiaries provide monitoring services and develop, manufacture and market telehealth systems for high-risk and chronically ill patients. The Company's segments consist of Sales of Systems, Services, and LifeWatch V. The Sale of Systems segment is engaged in the development, manufacture and marketing of trans-telephonic and wireless diagnostic equipment for the medical industry. The Lifewatch V segment is a mobile medical device platform designed for self-testing of vital signs for the consumer market. The services segment is engaged in cardiac event monitoring, pacemaker, ambulatory heart monitoring device and sleep disorder services.

Ratios

vs
industry
vs
history
Forward PE Ratio 66.67
LFWWF's Forward PE Ratio is ranked lower than
97% of the 111 Companies
in the Global Medical Devices industry.

( Industry Median: 21.79 vs. LFWWF: 66.67 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PB Ratio 4.60
LFWWF's PB Ratio is ranked lower than
62% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 3.11 vs. LFWWF: 4.60 )
Ranked among companies with meaningful PB Ratio only.
LFWWF' s PB Ratio Range Over the Past 10 Years
Min: 0.39  Med: 3.03 Max: 9.13
Current: 4.6
0.39
9.13
PS Ratio 1.95
LFWWF's PS Ratio is ranked higher than
66% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. LFWWF: 1.95 )
Ranked among companies with meaningful PS Ratio only.
LFWWF' s PS Ratio Range Over the Past 10 Years
Min: 0.33  Med: 1.42 Max: 2.95
Current: 1.95
0.33
2.95
EV-to-EBIT -31.52
LFWWF's EV-to-EBIT is ranked lower than
99.99% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 24.54 vs. LFWWF: -31.52 )
Ranked among companies with meaningful EV-to-EBIT only.
LFWWF' s EV-to-EBIT Range Over the Past 10 Years
Min: -72  Med: -3.4 Max: 926.6
Current: -31.52
-72
926.6
EV-to-EBITDA 132.87
LFWWF's EV-to-EBITDA is ranked lower than
95% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 19.31 vs. LFWWF: 132.87 )
Ranked among companies with meaningful EV-to-EBITDA only.
LFWWF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -113.6  Med: 6.1 Max: 216.4
Current: 132.87
-113.6
216.4
Current Ratio 1.10
LFWWF's Current Ratio is ranked lower than
86% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 2.38 vs. LFWWF: 1.10 )
Ranked among companies with meaningful Current Ratio only.
LFWWF' s Current Ratio Range Over the Past 10 Years
Min: 0.45  Med: 1.78 Max: 4.56
Current: 1.1
0.45
4.56
Quick Ratio 1.07
LFWWF's Quick Ratio is ranked lower than
76% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 1.79 vs. LFWWF: 1.07 )
Ranked among companies with meaningful Quick Ratio only.
LFWWF' s Quick Ratio Range Over the Past 10 Years
Min: 0.41  Med: 1.59 Max: 3.85
Current: 1.07
0.41
3.85
Days Inventory 8.33
LFWWF's Days Inventory is ranked higher than
97% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 130.04 vs. LFWWF: 8.33 )
Ranked among companies with meaningful Days Inventory only.
LFWWF' s Days Inventory Range Over the Past 10 Years
Min: 8.33  Med: 16.75 Max: 61.09
Current: 8.33
8.33
61.09
Days Sales Outstanding 39.80
LFWWF's Days Sales Outstanding is ranked higher than
89% of the 272 Companies
in the Global Medical Devices industry.

( Industry Median: 68.94 vs. LFWWF: 39.80 )
Ranked among companies with meaningful Days Sales Outstanding only.
LFWWF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 34.41  Med: 47.31 Max: 74.02
Current: 39.8
34.41
74.02
Days Payable 37.57
LFWWF's Days Payable is ranked lower than
71% of the 259 Companies
in the Global Medical Devices industry.

( Industry Median: 59.71 vs. LFWWF: 37.57 )
Ranked among companies with meaningful Days Payable only.
LFWWF' s Days Payable Range Over the Past 10 Years
Min: 30.76  Med: 49.44 Max: 178.84
Current: 37.57
30.76
178.84

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -11.40
LFWWF's 3-Year Average Share Buyback Ratio is ranked lower than
70% of the 218 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. LFWWF: -11.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
LFWWF' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -11.4  Med: -2.2 Max: 0.5
Current: -11.4
-11.4
0.5

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 182.29
LFWWF's Price-to-Net-Current-Asset-Value is ranked lower than
99% of the 206 Companies
in the Global Medical Devices industry.

( Industry Median: 6.88 vs. LFWWF: 182.29 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
LFWWF' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0.54  Med: 10.7 Max: 182.29
Current: 182.29
0.54
182.29
Price-to-Tangible-Book 6.51
LFWWF's Price-to-Tangible-Book is ranked lower than
64% of the 263 Companies
in the Global Medical Devices industry.

( Industry Median: 4.11 vs. LFWWF: 6.51 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
LFWWF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.37  Med: 3.55 Max: 42.9
Current: 6.51
0.37
42.9
Price-to-Median-PS-Value 1.38
LFWWF's Price-to-Median-PS-Value is ranked lower than
65% of the 242 Companies
in the Global Medical Devices industry.

( Industry Median: 1.03 vs. LFWWF: 1.38 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
LFWWF' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.3  Med: 0.87 Max: 1.81
Current: 1.38
0.3
1.81
Earnings Yield (Greenblatt) % -3.17
LFWWF's Earnings Yield (Greenblatt) % is ranked lower than
68% of the 432 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. LFWWF: -3.17 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
LFWWF' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -3.17  Med: 4.7 Max: 2168.4
Current: -3.17
-3.17
2168.4

More Statistics

Revenue (TTM) (Mil) $113.8
EPS (TTM) $ -0.86
Beta0.29
Short Percentage of Float0.00%
52-Week Range $9.47 - 16.38
Shares Outstanding (Mil)18.46

Analyst Estimate

Dec17 Dec18
Revenue (Mil $) 123 134
EPS ($) 0.19 0.21
EPS without NRI ($) 0.19 0.21
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for LFWWF

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
No related articles found.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)